NEPHROENDO Next Generation: Things They Don't Teach You in Medical School

Students nephrology section, School of medicine, University of Zagreb

Jelena Kovačić

Neck ultrasound

Tomislav Jukić

POCUS for nurses and students

Ivan Jerković, Điđi Delalić

Nutritional status evaluation

Lea Katalinić, Matea Murić Begić

Nurses symposium — Where Kidneys and Hormones Meet

Mirjana Mihalić

8:15-8:30

Arresting Diabetic nephropathy in type 1 diabetes

Chantal Mathieu

8:30-8:45

Breakthroughs in Diabetic Kidney Disease in type 1 Diabetes

Ljiljana Lukić

8:45-9:00

TBD

Dario Rahelić

9:00-9:15

Diabetic Kidney Disease as a Driver of Cardiac Electrical Remodeling

Borka Pezo

9:15-9:30

The Evolution of Antidiabetic Drugs: Beyond Glycaemic Control

Tatjana Milenković

9:30-9:45

Antiinflammatory biologics in diabetic kidney disease

Lea Katalinić

9:45-10:00

Mitochondrial dysfunction in diabetic kidney disease

Jerko Barbić

10:00-10:15

Precision glycemic targets in advanced CKD

Marin Deškin

10:15-10:30

Diabetic Kidney disease as a model of early vascular ageing

Vladimir Prelević

10:30-10:45

Progesterone Fluctuations and Their Effects on Insulin Sensitivity

Aleksandar Đogo

10:45-11:15

SPONSORED SYMPOSIUM Swixx

11:15-11:45

Coffee break

11:45-12:00

Managing the cardiometabolic continuum: the Position Statement from Europe East and South

Manfredi Rizzo

12:00-12:15

Cardiorenometabolic syndrome - a paradigm of integrative medicine

Snježana Popović-Pejičić

12:15-12:30

Integrating SGLT2i, GLP1RA and MRAs across CKD stages

Josipa Radić

  • ACEi/ARB + SGLT2 inhibitor + Non-Steroidal MRA — For Every Patient with diabetic CKD?
13:00-13:15

SPONSORED SYMPOSIUM AstraZeneca

13:15-14:00

Lunch

14:00-14:15

Primary hyperparathyreoidism and kidney

Marija Milinković

14:15-14:30

Diagnostics and treatment of primary hyperparathyreoidism

Tomislav Jukić

14:30-14:45

Osteoporosis and CKD

Mirjana Laušević

14:45-15:00

Posttransplant bone disease

Bojana Šimunov

15:00-15:15

When Laboratory Values Lie: Challenges in Endocrine Testing in CKD

Ivana Lapić

15:15-15:30

CKD-MBD from a Laboratory Perspective: Biomarkers in the Evaluation of Bone and Mineral Disorders

Dragana Šegulja

15:30-15:45

SPONSORED SYMPOSIUM Medilab

15:45-16:15

Coffee break

16:15-16:30

Mild Autonomous Cortisol Secretion: A Hidden Driver of Metabolic-Cardiorenal Disease

Silvija Canecki-Varžić

16:30-16:45

Rethinking Primary Aldosteronism: A New Era of Screening

Dubravka Jurišić-Eržen

16:45-17:00

The Dark Side of Aldosterone: From Adaptive Hormone to Organ Damage

Ines Bilić Ćurčić

17:00-17:15

Androgen Excess Across Organ Systems: Why Nephrologists Should Care?

Mladen Krnić

17:15-17:35

Coffee break

  • What Clinicians Miss?
  • Should we screen all ESRD patients for endocrine dysfunction?
  • Which conditions truly require treatment?
18:00-18:15

The Obesity-Kidney-Diabetes Axis: What Can We Do in Primary Care?

Valerija Bralić Lang

18:15-18:30

Euglycemic ketoacidosis

Ivan Jerković

18:30-18:45

Metabolic dysfunction-associated steatotic liver disease in chronic kidney disease

Anna Mrzljak

18:45-19:00

Tumors of endocrine glands in patients with chronic kidney disease

Ivana Tolj

19:00-19:15

Obesity in the ICU: Challenges in Drug Dosing, Ventilation and Kidney Replacement Therapy

Ana Vujaklija Brajković

19:15-19:30

AVF does not like sweets

Alena Srdalić

20:30

Dinner

  • The First 6 Hours: Managing the Cardio-Renal-Metabolic Emergency Patient

Do we (still) need lipid apheresis?

Nikolina Bašić Jukić

9:20-9:35

Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis are Associated with Advanced Cardiovascular-Kidney-Metabolic Syndrome

Damir Rebić

9:35-9:50

Dyslipidemia in CKD: beyond LDL - understanding the unique lipid phenotype

Ivan Pećin

9:50-10:05

Therapeutic strategies in CKD dyslipidemia: evidence, controversies and new agents

Nediljko Šućur

10:05-10:20

SPONSORED SYMPOSIUM Novartis

10:20-10:45

Coffee break

10:45-11:00

Obesity and Early Vascular Ageing in Hypertensive Youth: Why It Matters?

Vesna Herceg-Čavrak

11:00-11:15

The Hidden Inflammation of Obesity: When the Brain Becomes the Target

Vanja Bašić Kes

11:15-11:30

Integrative care for obese patients with CKD

Martina Matovinović

11:30-11:45

From guidelines to clinical practice - and back

Andrej Belančić

11:45-12:15

Obesity debate

Moderator: Nikolina Bašić Jukić

Ana Soldo, Ingrid Prkačin, Ana-Marija Liberati Pršo, Marija Kušan Jukić, Andrej Belančić, Martina Matovinović, Vanja Bašić Kes

12:15-12:45

SPONSORED SYMPOSIUM Eli Lilly

12:45-13:45

Lunch

13:45-14:00

Micronutrition in patients with chronic kidney disease

Ana Marija Liberati-Pršo

14:00-14:15

Bioelectric impedance spectroscopy in evaluation of patients with CKD

Ingrid Prkačin

14:15-14:30

Gut microbiome-uremia-insulin resistance axis

Tihana Šimundić

14:30-14:45

Nutritional challenges in peritoneal dialysis patients - can we overcome obesity and diabetes?

Božidar Vujičić

14:45-15:00

Supplementation Across the CKD Journey: From Early Disease to Dialysis and Transplantation

Mateja Murić Begić

15:00-15:20

SPONSORED SYMPOSIUM Ventive

15:20-15:40

FGF 23 in health and disease

Pinaki Dutta

15:40-15:55

Klotho replacement strategies

Danilo Radunović

15:55-16:10

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease

Jasmina Matijašević Škerlj

16:10-16:25

Calcitriol in treatment of secondary hyperparathyreoidism

Aida Ćorić

16:25-16:45

Coffee break

16:45-17:00

GLP-1 Receptor Agonists and SGLT2 Inhibitors in Acute Illness: When to Stop and When to Restart

Miran Miljak

17:00-17:15

SGLT-2 inhibitors and risk of sarcopenia

Marijana Gulin

17:15-17:30

Simultaneous kidney-pancreas transplantation: challenge for anesthesia and postoperative recovery

Iva Bačak Kocman

17:30-17:45

The syndrome of inappropriate antidiuretic hormone secretion in acute porphyria

Zoran Mišković

17:45-17:55

Hyperuricemia After GLP-1 and SGLT2: Do We Need Urate-Lowering Therapy Anymore?

Matea Milanović

17:55-18:05

Uric Acid in 2026: Time to Stop Treating Numbers—or Time to Start Earlier?

Lara Stanković Barac

8:30-8:45

(In)fertility and renal replacement therapy

Živka Dika

8:45-9:00

Aldosteron driven menopause-adipocyte crosstalk in the progression of chronic kidney disease

Marijana Živko

9:00-9:15

Dysmetabolic infertility in the shadow of chronic kidney disease - a quest for answers to challenges and mysteries

Sanja Medenica

9:15-9:35

Androgen deficiency in males with chronic kidney disease: an untapped therapeutic potential

Richard Quinton

9:35-9:50

Chronic kidney disease and arterial stiffness

Bojan Jelaković

9:50-10:05

Arterial stiffness in chronic kidney disease - ArSti-CKD study

Ana Jelaković

10:05-10:20

ePWV as a predictor for the CKD progression

Marija Domislović

10:20-10:35

Influence of viral infections on ePWV in kidney transplant recipients

Marina Kljajić

10:35-11:05

Coffee break

11:05-11:20

Redefining Normal: Age-Related Changes in TSH and Thyroid Hormones

Miro Bakula and Kristian Lipovac

11:20-11:35

Autoimmune Thyroid Disease and the Kidney: An Overlooked Connection

Jelena Vučak

11:35-11:50

The Impact of Hypo- and Hyperthyroidism on Kidney Function

Gorana Mirošević

11:50-12:05

Thyroid Dysfunction in Chronic Kidney Disease: Clinical Implications for Nephrologists

Kristina Kljajić

12:05-12:20

Myxedematous coma

Ivan Jerković

12:20-12:35

The Thyroid-Kidney crosstalk: from advanced CKD to kidney replacement therapy

Ita Jelić Pranjić

12:35-12:50

Epigenetics of CKD progression

Ingrid Prkačin

12:50-13:05

Endocrine disruptors and chronic kidney disease

Ljiljana Fodor

13:05-13:20

From uremia to immunometabolism: the hormonal reset after kidney transplant

Armin Atić

13:20-13:35

Joining Forces for diagnosis: rare diseases at the crossroads of endocrinology and nephrology

Maša Davidović and Katja Dumić-Kubat

13:35-13:50

Genomic and non-genomic effects of different doses and different preparations of glucocorticoids

Josipa Josipović

13:50-14:00

Hypophosphatemia - The Forgotten Complication of Acute Dialysis

Alan Horvat

Program je podložan promjenama. Pratite nas za najnovije informacije.